Are CRISPR Screens Providing the Next Generation of Therapeutic Targets?

Area of Science:

• Oncology
• Genomics
• Drug Discovery

Background:

• CRISPR screens combined with molecular and genetic profiling are advancing cancer vulnerability identification.
• Large-scale screens have identified promising targets, initiating drug discovery programs with some reaching clinical trials.

Purpose of the Study:

• To systematically identify cancer vulnerabilities using CRISPR screens.
• To explore opportunities for discovery in loss-of-function studies, addressing limitations in current models and screening methods.

Main Methods:

• Utilizing CRISPR screens with molecular and genetic profiling of extensive cell line panels.
• Conducting focused in vivo and isogenic cell line screens.

Main Results:

• Identification of a growing number of promising cancer targets.
• Initiation of numerous target-specific drug discovery programs, with several entering clinical testing.

Conclusions:

• CRISPR screens are instrumental in discovering cancer dependencies and therapeutic targets.
• Overcoming challenges like genetic redundancy and model limitations will be key for future oncology drug development.